AWM
BSX icon

Abound Wealth Management’s Boston Scientific BSX Stock Holding History

Abound Wealth Management’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$49.7K Sell
1,163
-211
-15% -$11.5K 0.01% 239
2026
Q1 		$86.2K Sell
1,374
-35
-2% -$2.8K 0.02% 164
2025
Q4 		$134K Buy
1,409
+730
+108% +$71.6K 0.03% 114
2025
Q3 		$66.3K Hold
679
– – 0.02% 177
2025
Q2 		$72.9K Buy
679
+447
+193% +$45.2K 0.02% 158
2025
Q1 		$23.4K Sell
232
-75
-24% -$7.55K 0.01% 273
2024
Q4 		$27.4K Sell
307
-41
-12% -$3.61K 0.01% 240
2024
Q3 		$29.1K Buy
348
+74
+27% +$5.83K 0.01% 235
2024
Q2 		$21.1K Sell
274
-61
-18% -$4.46K 0.01% 244
2024
Q1 		$22.9K Buy
335
+67
+25% +$4.31K 0.01% 222
2023
Q4 		$15.5K Sell
268
-22
-8% -$1.17K 0.01% 311
2023
Q3 		$15.3K Buy
290
+50
+21% +$2.62K 0.01% 256
2023
Q2 		$13K Buy
240
+14
+6% +$731 0.01% 293
2023
Q1 		$11.3K Buy
226
+63
+39% +$2.97K 0.01% 274
2022
Q4 		$7.54K Sell
163
-20
-11% -$866 ﹤0.01% 296
2022
Q3 		$7.09K Buy
+183
New +$7.34K ﹤0.01% 320

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Abound Wealth Management's BSX Position: Q2 2026 in Review

Abound Wealth Management reduced its Boston Scientific (BSX) stake by 15% in Q2 2026, selling an estimated $11.5K and leaving 1,163 shares worth $49.7K. The position accounts for 0.01% of the portfolio, ranked #239.

Abound Wealth Management first reported a position in BSX in Q3 2022 and has held it in 16 quarters since. The position peaked at $134K in Q4 2025. 1,470 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Abound Wealth Management held 1,163 shares of Boston Scientific worth $49.7K as of Q2 2026.
  • Abound Wealth Management sold 211 Boston Scientific shares in Q2 2026, an estimated $11.5K.
  • Boston Scientific made up 0.01% of Abound Wealth Management's portfolio in Q2 2026, its #239 holding.
  • Abound Wealth Management first reported a position in Boston Scientific in Q3 2022 and has held it in 16 quarters since.
  • Abound Wealth Management's Boston Scientific position peaked at $134K in Q4 2025.
  • 1,470 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Abound Wealth Management's 13F filing for Q2 2026, filed 10 Jul 2026.